Cite
APA Citation
Decaens, T., Barone, C., Assenat, E., Wermke, M., Fasolo, A., Merle, P., Blanc, J., Grando, V., Bruns, R., Straub, J., Zhao, C., & Faivre, S. (n.d.). 152OEfficacy and safety of the Met inhibitor tepotinib in patients (pts) with advanced Met+ hepatocellular carcinoma (HCC) previously treated with sorafenib. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095497035.0x00003c